2026年全球生物材料市場報告

近年來，生醫材料市場發展迅速，預計2025年至2026年將以13.9%的複合年成長率從1514.7億美元成長至1725.4億美元。過去幾年的成長可歸因於整形外科和人工植牙手術的增加、心血管疾病盛行率的上升、醫療基礎設施的改善、聚合物和金屬加工技術的進步以及醫療植入的日益普及。

預計未來幾年生醫材料市場將快速成長，到2030年市場規模將達到2,844.4億美元，複合年成長率（CAGR）為13.3%。預測期內的成長要素包括全球人口老化、再生醫學需求不斷成長、生醫材料3D列印技術的進步、生物醫學研究投資的增加以及在神經系統疾病和創傷治療治療領域應用範圍的擴大。預測期內的主要趨勢包括對生物相容性和生物活性材料的需求不斷成長、可生物分解生醫材料的日益普及、生醫材料在組織工程中的應用日益廣泛、先進植入式醫療設備的日益普及以及對客製化化、患者特異性生醫材料的日益關注。

醫療費用支出不斷成長預計將推動生醫材料市場的發展。醫療費用支出是指在特定時期內（通常指國家或機構層級）用於醫療服務、治療和醫療基礎設施的總資金。其中一部分支出用於生物材料的研究與開發、採購、實施和監管合規。例如，美國醫學會 (AMA) 報告稱，2023 年美國醫療保健總支出將達到 48,665 億美元（人均 14,570 美元）。這比前一年成長了 7.5%，較 2022 年的 4.6% 增幅顯著。醫療保健支出不斷成長預計將推動生醫材料市場的發展。

為了提供永續的生物聚合物並獲得競爭優勢，生醫材料市場的主要企業正致力於技術創新，例如工程酶生醫材料（DEB）技術平台。 DEB技術生醫材料利用酵素來設計和改造材料，以應用於藥物遞送、組織工程和診斷等多種領域。例如，2023年6月，總部位於美國的香精香料和化妝品活性成分製造商國際香料香精公司（IFF）宣布推出其用於大規模開發生物基材料的酵素生醫材料技術平台。 DEB技術旨在提供顯著的永續性優勢，同時提供與化石基材料相當甚至更優的性能，從而滿足日益成長的環保高性能生物聚合物的需求。該技術平台使生產商能夠透過取代傳統的化石基合成聚合物來應對監管變化並滿足不斷成長的消費者需求。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球生物材料市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 永續性、氣候技術和循環經濟
  • 人工智慧與自主智慧
  • 工業4.0和智慧製造
  • 數位化、雲端運算、巨量資料和網路安全
• 主要趨勢
  • 對生物相容性和生物活性材料的需求日益成長
  • 擴大可生物分解生物材料的應用
  • 擴大生物材料在組織工程的應用
  • 先進植入式醫療設備的興起
  • 越來越關注客製化、病患特異性生物材料

第5章 終端用戶產業市場分析

• 醫院
• 診所
• 門診手術中心
• 專業醫療中心
• 研究和學術機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球生物材料市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球生物材料市場規模、比較及成長率分析
• 全球生物材料市場表現：規模與成長，2020-2025年
• 全球生物材料市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

• 按類型
• 金屬生物材料、聚合物生物材料、天然生物材料、陶瓷
• 透過使用
• 循環系統系統、整形外科、眼科、牙科、整形外科、創傷治療、組織工程、神經系統/中樞神經系統
• 按最終用途
• 醫院及診所、門診手術中心等終端用戶
• 金屬生物材料按類型細分
• 不銹鋼、鈦合金、鈷鉻合金、鎂合金
• 按類型對聚合物基生物材料進行細分
• 合成聚合物、天然聚合物、可生物分解聚合物
• 天然生物材料按類型細分
• 動物源性材料、植物來源材料
• 陶瓷細分，依類型
• 生物陶瓷、多孔陶瓷、非多孔陶瓷

第10章 區域與國家分析

• 全球生物材料市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
• 全球生物材料市場：依國家分類、績效及預測（2020-2025年、2025-2030年預測、2035年預測）

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 生物材料市場：競爭格局及市場佔有率（2024年）
• 生物材料市場：公司估值矩陣
• 生物材料市場：公司概況
  • Corbion NV
  • Evonik Industries AG
  • Heraeus Medical Components LLC
  • Berkeley Advanced Biomaterials Inc.
  • Zimmer Biomet Holdings Inc.

第37章：其他領先和創新企業

• DSM Biomedical BV, PolyNovo Limited, Baxter International Inc., Stryker Corporation, Collagen Solutions plc, Invibio Ltd., Aap Implantate AG, Cam Bioceramics BV, CeramTec GmbH, CoorsTek Medical LLC, CryoLife Inc., Cerapedics Inc., Surmodics Inc., Secant Group LLC, GELITA AG

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年生物材料市場：提供新機會的國家
• 2030年生物材料市場：充滿新機會的細分市場
• 2030年生物材料市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

The biomaterials refer to manmade substances that can be utilized to support tissues or structures in the body. These are natural or synthetic materials that are used in medical applications to support, enhance, or replace damaged tissue or a biological function.

The main types of biomaterials are metallic biomaterial, polymeric biomaterials, natural biomaterials and ceramics. The metallic biomaterials are stainless steels, titanium alloys, and cobalt alloys used to provide internal support to biological tissues. The metallic biomaterials are manmade systems that are utilized in joint replacements, dental implants, orthopedic fixations, and stents to offer internal support to biological tissues. Biomaterials have a wide application in cardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering and neurological/central nervous system and are used in hospitals and clinics, ambulatory surgical centers and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs on specialty metals, polymers, and ceramic materials have impacted the biomaterials market by increasing raw material and manufacturing costs, particularly for metallic and polymeric biomaterials used in implants and medical devices. Regions such as North America, Europe, and Asia-Pacific are most affected due to their dependence on global supply chains for titanium alloys, polymers, and bioceramics. While tariffs have created cost pressures and pricing challenges, they have also encouraged local manufacturing, material innovation, and supply chain diversification, supporting long-term resilience in the biomaterials industry.

The biomaterials market research report is one of a series of new reports from The Business Research Company that provides biomaterials market statistics, including biomaterials industry global market size, regional shares, competitors with a biomaterials market share, detailed biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the biomaterials industry. This biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biomaterials market size has grown rapidly in recent years. It will grow from $151.47 billion in 2025 to $172.54 billion in 2026 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to growth in orthopedic and dental implant procedures, rising prevalence of cardiovascular diseases, increased healthcare infrastructure development, advancements in polymer and metal processing technologies, growing adoption of medical implants.

The biomaterials market size is expected to see rapid growth in the next few years. It will grow to $284.44 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to aging global population, increasing demand for regenerative medicine, advancements in 3d printing of biomaterials, rising investment in biomedical research, expanding applications in neurological and wound healing treatments. Major trends in the forecast period include rising demand for biocompatible and bioactive materials, growing adoption of biodegradable biomaterials, increasing use of biomaterials in tissue engineering, expansion of advanced implantable medical devices, rising focus on customized and patient-specific biomaterials.

The rising healthcare spending is expected to drive the growth of the biomaterials market. Healthcare spending refers to the total financial resources allocated for medical services, treatments, and healthcare infrastructure over a specific period, typically at a national or institutional level. A portion of this spending is directed toward the research, development, procurement, adoption, and regulatory compliance of biomaterials. For example, in 2025, according to the American Medical Association (AMA), a U.S.-based professional association, the United States spent a total of $4,866.5 billion, or $14,570 per capita, on healthcare in 2023. This represents a 7.5% increase from the previous year, reflecting a significant rise compared to the 4.6% growth seen in 2022. As healthcare spending increases, it will contribute to the growth of the biomaterials market.

Major companies operating in the biomaterials market focus on technological advancements, such as the designed enzymatic biomaterials (DEB) technology platform, to deliver sustainable biopolymers and gain a competitive advantage. The enzymatic biomaterials (DEB) technology platform involves the use of enzymes to design and modify materials for various applications, including drug delivery, tissue engineering, and diagnostics. For instance, in June 2023, International Flavors & Fragrances Inc., a US-based producer of flavors, fragrances, and cosmetic actives, launched the enzymatic biomaterials technology platform for the development of biobased materials at scale. Designed to deliver meaningful sustainability benefits with performance comparable to or superior to fossil-based materials, DEB technology helps to address growing preferences for environmentally friendly, high-performance biopolymers. The technology platform allows producers to fulfill regulatory changes and increasing consumer demand by replacing traditional fossil-based synthetic polymers.

In October 2024, RTI Surgical (RTI), a US-based medical equipment manufacturing company, acquired Collagen Solutions plc for an undisclosed amount. The objective of RTI Surgical's acquisition of Collagen Solutions is to broaden its soft tissue portfolio and improve its capabilities in the regenerative medicine sector. Collagen Solutions plc is a US-based supplier, developer, and manufacturer of medical-grade collagen, tissues, and other biomaterials for use in regenerative medicine, medical devices, and research.

Major companies operating in the biomaterials market report are Corbion N V, Evonik Industries AG, Heraeus Medical Components LLC, Berkeley Advanced Biomaterials Inc., Zimmer Biomet Holdings Inc., DSM Biomedical BV, PolyNovo Limited, Baxter International Inc., Stryker Corporation, Collagen Solutions plc, Invibio Ltd., Aap Implantate AG, Cam Bioceramics BV, CeramTec GmbH, CoorsTek Medical LLC, CryoLife Inc., Cerapedics Inc., Surmodics Inc., Secant Group LLC, GELITA AG, Kyocera Corporation, Wright Medical Group NV, KLS Martin Group GmbH & Co KG, Meccellis Biotechnology Co Ltd., Bio-on SpA, Coloplast A/S, Collagen Matrix Inc., IntrinsiQ Materials Inc., PolyActiva Pty Ltd

North America was the largest region in the biomaterials market in 2025. The regions covered in the biomaterials market are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biomaterials market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biomaterials market consists of sales of metals, polymers, and composites. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biomaterials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biomaterials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Metallic Biomaterial; Polymeric Biomaterials; Natural Biomaterials; Ceramics
• 2) By Application: Cardiovascular; Orthopedic; Ophthalmology; Dental; Plastic Surgery; Wound Healing; Tissue Engineering; Neurological/Central Nervous System
• 3) By End Use: Hospitals And Clinics; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Metallic Biomaterials: Stainless Steel; Titanium Alloys; Cobalt-Chromium Alloys; Magnesium Alloys
• 2) By Polymeric Biomaterials: Synthetic Polymers; Natural Polymers; Biodegradable Polymers
• 3) By Natural Biomaterials: Animal-Derived Materials; Plant-Derived Materials
• 4) By Ceramics: Bioceramics; Porous Ceramics; Non-porous Ceramics
• Companies Mentioned: Corbion N V; Evonik Industries AG; Heraeus Medical Components LLC; Berkeley Advanced Biomaterials Inc.; Zimmer Biomet Holdings Inc.; DSM Biomedical BV; PolyNovo Limited; Baxter International Inc.; Stryker Corporation; Collagen Solutions plc; Invibio Ltd.; Aap Implantate AG; Cam Bioceramics BV; CeramTec GmbH; CoorsTek Medical LLC; CryoLife Inc.; Cerapedics Inc.; Surmodics Inc.; Secant Group LLC; GELITA AG; Kyocera Corporation; Wright Medical Group NV; KLS Martin Group GmbH & Co KG; Meccellis Biotechnology Co Ltd.; Bio-on SpA; Coloplast A/S; Collagen Matrix Inc.; IntrinsiQ Materials Inc.; PolyActiva Pty Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Biomaterials Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Biomaterials Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Biomaterials Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Biomaterials Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Sustainability, Climate Tech & Circular Economy
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
• 4.2. Major Trends
  • 4.2.1 Rising Demand For Biocompatible And Bioactive Materials
  • 4.2.2 Growing Adoption Of Biodegradable Biomaterials
  • 4.2.3 Increasing Use Of Biomaterials In Tissue Engineering
  • 4.2.4 Expansion Of Advanced Implantable Medical Devices
  • 4.2.5 Rising Focus On Customized And Patient-Specific Biomaterials

5. Biomaterials Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Ambulatory Surgical Centers
• 5.4 Specialty Medical Centers
• 5.5 Research And Academic Institutes

6. Biomaterials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biomaterials Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Biomaterials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Biomaterials Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Biomaterials Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Biomaterials Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biomaterials Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biomaterials Market Segmentation

• 9.1. Global Biomaterials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Metallic Biomaterial, Polymeric Biomaterials, Natural Biomaterials, Ceramics
• 9.2. Global Biomaterials Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurological/Central Nervous System
• 9.3. Global Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users
• 9.4. Global Biomaterials Market, Sub-Segmentation Of Metallic Biomaterials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Stainless Steel, Titanium Alloys, Cobalt-Chromium Alloys, Magnesium Alloys
• 9.5. Global Biomaterials Market, Sub-Segmentation Of Polymeric Biomaterials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Synthetic Polymers, Natural Polymers, Biodegradable Polymers
• 9.6. Global Biomaterials Market, Sub-Segmentation Of Natural Biomaterials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Animal-Derived Materials, Plant-Derived Materials
• 9.7. Global Biomaterials Market, Sub-Segmentation Of Ceramics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bioceramics, Porous Ceramics, Non-porous Ceramics

10. Biomaterials Market Regional And Country Analysis

• 10.1. Global Biomaterials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Biomaterials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biomaterials Market

• 11.1. Asia-Pacific Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biomaterials Market

• 12.1. China Biomaterials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biomaterials Market

• 13.1. India Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biomaterials Market

• 14.1. Japan Biomaterials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biomaterials Market

• 15.1. Australia Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biomaterials Market

• 16.1. Indonesia Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biomaterials Market

• 17.1. South Korea Biomaterials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biomaterials Market

• 18.1. Taiwan Biomaterials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biomaterials Market

• 19.1. South East Asia Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biomaterials Market

• 20.1. Western Europe Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biomaterials Market

• 21.1. UK Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biomaterials Market

• 22.1. Germany Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biomaterials Market

• 23.1. France Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biomaterials Market

• 24.1. Italy Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biomaterials Market

• 25.1. Spain Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biomaterials Market

• 26.1. Eastern Europe Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biomaterials Market

• 27.1. Russia Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biomaterials Market

• 28.1. North America Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biomaterials Market

• 29.1. USA Biomaterials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biomaterials Market

• 30.1. Canada Biomaterials Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biomaterials Market

• 31.1. South America Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biomaterials Market

• 32.1. Brazil Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biomaterials Market

• 33.1. Middle East Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biomaterials Market

• 34.1. Africa Biomaterials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biomaterials Market Regulatory and Investment Landscape

36. Biomaterials Market Competitive Landscape And Company Profiles

• 36.1. Biomaterials Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Biomaterials Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Biomaterials Market Company Profiles
  • 36.3.1. Corbion N V Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Heraeus Medical Components LLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Berkeley Advanced Biomaterials Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Biomaterials Market Other Major And Innovative Companies

• DSM Biomedical BV, PolyNovo Limited, Baxter International Inc., Stryker Corporation, Collagen Solutions plc, Invibio Ltd., Aap Implantate AG, Cam Bioceramics BV, CeramTec GmbH, CoorsTek Medical LLC, CryoLife Inc., Cerapedics Inc., Surmodics Inc., Secant Group LLC, GELITA AG

38. Global Biomaterials Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biomaterials Market

40. Biomaterials Market High Potential Countries, Segments and Strategies

• 40.1 Biomaterials Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Biomaterials Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Biomaterials Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer